Announcements Trials

Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2 Myeloid 2 Other hematologic neoplasm 1 Genitourinary 1 Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 1

Interventions

Magnetic Resonance Spectroscopy 98 Specimen Handling 79 pembrolizumab 75 enzalutamide 63 Nivolumab 59 Gemcitabine 54 Docetaxel 50 apalutamide 42 Radiosurgery 41 Abiraterone Acetate 40 Androgen Antagonists 39 Prednisone 38 Biopsy 37 darolutamide 35 Cisplatin 35 cabozantinib 31 Radiotherapy 31 Carboplatin 28 Pluvicto 27 abiraterone 26 enfortumab vedotin 24 Ipilimumab 24 Radiation 23 durvalumab 22 atezolizumab 22 Leuprolide 20 olaparib 18 X-Rays 18 Standard of Care 18 avelumab 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

canakinumab × Genitourinary × 90 days × Clear all

NCT04028245 2026-04-15

SPARC-1

Columbia University

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡